H.R. 5145 - To Amend Title XIX of the Social Security Act to Exclude Abuse-Deterrent Formulations of Prescription Drugs from the Medicaid Additional Rebate Requirement for New Formulations of Prescription Drugs, and for Other Purposes.
Health. 114th Congress (2015-2016) View bill details
- Sponsor:
- Gus M. Bilirakis
- Summary:
- To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes. (by CRS)
- Status:
- The bill has been referred to committee.
There have been no votes on this bill.
To Amend Title XIX of the Social Security Act to Exclude Abuse-Deterrent Formulations of Prescription Drugs from the Medicaid Additional Rebate Requirement for New Formulations of Prescription Drugs, and for Other Purposes.
H.R. 5145 — 114th Congress (2015–2016)
- Summary
- To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.
- Other Titles
- To amend title XIX of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the Medicaid additional rebate requirement for new formulations of prescription drugs, and for other purposes.
- Sponsor
- Gus M. Bilirakis
- Co-Sponsors
- Subjects
- Health
- Child health
- Drug trafficking and controlled substances
- Drug, alcohol, tobacco use
- Fraud offenses and financial crimes
- Freedom of information
- Government information and archives
- Government studies and investigations
- Health care costs and insurance
- Health information and medical records
- Health programs administration and funding
- Medicaid
- Medicare
- Prescription drugs
- Public contracts and procurement
- Related Bills
- Major Actions
Introduced 4/29/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 4/29/2016 4/29/2016 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 4/29/2016 Introduced in House 5/06/2016 Referred to the Subcommittee on Health. 5/17/2016 Referred to the Subcommittee on Health. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Includes reported contributions to congressional campaigns of House members in office during the 114th U.S. Congress, from interest groups invested in the vote according to MapLight, November 29, 2014 – November 28, 2016.
Contributions data source: OpenSecrets.org
Contributions data source: OpenSecrets.org
